# Vaxart, Inc.: filings

VXRT · OTC · CIK 72444 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vxrt.md) · [Financials](/companies/vxrt/financials.md) · [Filings](/companies/vxrt/filings.md) · [Insiders](/companies/vxrt/insiders.md)

## Reports and events: 451 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 323, 8-K 300, DEFA14A 80, 10-Q 54, 3 45, SC 13G/A 34, SC 13D/A 31, UPLOAD 24, CORRESP 22, SC 13G 22, 10-K 17, 424B5 17, 425 16, DEF 14A 16, EFFECT 16, DFAN14A 13, 8-K/A 12, 4/A 11, S-8 9, SC 13D 9, PRE 14A 8, ARS 7, POS AM 7, CT ORDER 6, S-1/A 5, S-3 5, 11-K 4, DEFC14A 4, PREC14A 4, 10-K/A 3, PRRN14A 3, PX14A6G 3, S-1 3, S-3/A 3, SC TO-I/A 3, 144 2, 424B3 2, 424B4 2, 5 2, DEFM14A 2, NO ACT 2, NT 10-K 2, PREM14A 2, PRER14A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-Q/A 1, 25-NSE 1, 3/A 1, 424B2 1, 8-A12B 1, FWP 1, S-3ASR 1, S-4 1, S-4/A 1, S-8 POS 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:06 ET | [8-K](/filings/0001437749-26-032932.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-032932 |
| 2026-09-14 | 20:05 ET | [8-K](/filings/0001437749-26-030318.md) | 8.01 Other events | 0001437749-26-030318 |
| 2026-08-25 | 20:12 ET | [8-K](/filings/0001437749-26-028916.md) | 8.01 Other events | 0001437749-26-028916 |
| 2026-08-06 | 20:23 ET | [10-Q](/filings/0001437749-26-026289.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026289 |
| 2026-08-06 | 20:17 ET | [8-K](/filings/0001437749-26-026280.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026280 |
| 2026-07-28 | 12:00 ET | [8-K](/filings/0001437749-26-024560.md) | 8.01 Other events | 0001437749-26-024560 |
| 2026-07-17 | 20:10 ET | [8-K](/filings/0001437749-26-023762.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-023762 |
| 2026-07-07 | 12:00 ET | [8-K](/filings/0001437749-26-022876.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-022876 |
| 2026-07-02 | 10:20 ET | [8-K](/filings/0001213900-26-074576.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-074576 |
| 2026-06-26 | 20:07 ET | [8-K](/filings/0001437749-26-021833.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021833 |
| 2026-05-19 | 21:17 ET | [8-K](/filings/0001213900-26-059127.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-059127 |
| 2026-05-18 | 00:39 ET | [S-1/A](/filings/0001437749-26-017489.md) | Registration statement, amended | 0001437749-26-017489 |
| 2026-05-08 | 21:30 ET | [S-1](/filings/0001437749-26-015961.md) | Registration statement | 0001437749-26-015961 |
| 2026-05-07 | 20:25 ET | [10-Q](/filings/0001437749-26-015608.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015608 |
| 2026-05-07 | 20:15 ET | [8-K](/filings/0001437749-26-015586.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015586 |
| 2026-04-30 | 20:42 ET | [10-K/A](/filings/0001437749-26-014245.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-014245 |
| 2026-04-23 | 20:45 ET | [8-K](/filings/0001437749-26-013195.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-013195 |
| 2026-04-21 | 12:30 ET | [8-K](/filings/0001437749-26-012882.md) | 8.01 Other events | 0001437749-26-012882 |
| 2026-04-17 | 12:30 ET | [8-K](/filings/0001437749-26-012623.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012623 |
| 2026-03-13 | 21:55 ET | [10-K](/filings/0001437749-26-008023.md) | Annual report, period 2025-12-31 | 0001437749-26-008023 |
| 2026-03-12 | 20:11 ET | [8-K](/filings/0001437749-26-007968.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007968 |
| 2025-12-29 | 13:00 ET | [8-K](/filings/0001437749-25-038774.md) | 1.02 Termination of a material agreement | 0001437749-25-038774 |
| 2025-11-13 | 21:16 ET | [10-Q](/filings/0001437749-25-034840.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034840 |
| 2025-11-13 | 21:11 ET | [8-K](/filings/0001437749-25-034829.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034829 |
| 2025-11-05 | 21:30 ET | [8-K](/filings/0001437749-25-033362.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-033362 |
| 2025-10-10 | 21:00 ET | [8-K](/filings/0001437749-25-030868.md) | 7.01 Regulation FD disclosure | 0001437749-25-030868 |
| 2025-09-19 | 20:06 ET | [8-K](/filings/0001437749-25-029485.md) | 3.01 Delisting notice | 0001437749-25-029485 |
| 2025-09-19 | 10:00 ET | [8-K](/filings/0001437749-25-029434.md) | 8.01 Other events | 0001437749-25-029434 |
| 2025-09-08 | 20:37 ET | [8-K](/filings/0001437749-25-028570.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-028570 |
| 2025-09-02 | 21:09 ET | [8-K](/filings/0001437749-25-028167.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-028167 |
| 2025-08-29 | 20:44 ET | [8-K](/filings/0001437749-25-028047.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028047 |
| 2025-08-21 | 21:01 ET | [8-K](/filings/0001437749-25-027524.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027524 |
| 2025-08-15 | 17:25 ET | [8-K](/filings/0001437749-25-027110.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027110 |
| 2025-08-13 | 20:16 ET | [10-Q](/filings/0001437749-25-026514.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026514 |
| 2025-08-13 | 20:13 ET | [8-K](/filings/0001437749-25-026511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026511 |
| 2025-08-06 | 20:51 ET | [DEF 14A](/filings/0001437749-25-025111.md) | Proxy statement, period 2025-09-05 | 0001437749-25-025111 |
| 2025-08-06 | 12:00 ET | [8-K](/filings/0001437749-25-024955.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001437749-25-024955 |
| 2025-07-08 | 21:13 ET | [8-K](/filings/0001437749-25-022358.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-022358 |
| 2025-07-02 | 12:00 ET | [8-K](/filings/0001437749-25-021865.md) | 3.01 Delisting notice | 0001437749-25-021865 |
| 2025-06-17 | 20:20 ET | [8-K](/filings/0001437749-25-020651.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-020651 |
| 2025-06-11 | 12:18 ET | [8-K](/filings/0001437749-25-020040.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-020040 |
| 2025-06-02 | 20:56 ET | [8-K](/filings/0001437749-25-019181.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-019181 |
| 2025-05-28 | 18:58 ET | [8-K](/filings/0001437749-25-018648.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-018648 |
| 2025-05-28 | 12:30 ET | [8-K](/filings/0001437749-25-018591.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-018591 |
| 2025-05-22 | 21:34 ET | [8-K](/filings/0001437749-25-018021.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-018021 |
| 2025-05-16 | 12:30 ET | [8-K](/filings/0001437749-25-017302.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-017302 |
| 2025-05-15 | 12:30 ET | [8-K](/filings/0001437749-25-016997.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016997 |
| 2025-05-13 | 20:41 ET | [8-K](/filings/0001437749-25-016500.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016500 |
| 2025-05-13 | 20:13 ET | [10-Q](/filings/0001437749-25-016459.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016459 |
| 2025-05-13 | 20:09 ET | [8-K](/filings/0001437749-25-016447.md) | 2.02 Results of operations | 0001437749-25-016447 |

Page 1 of 10. [Older](/companies/vxrt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:53 ET. No prices; not investment advice.